Amphastar Pharmaceuticals Price to Book Ratio 2012-2023 | AMPH
Historical price to book ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current price to book ratio for Amphastar Pharmaceuticals as of April 26, 2024 is 3.08.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Amphastar Pharmaceuticals Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-04-26 |
41.11 |
|
3.09 |
| 2023-12-31 |
61.85 |
$13.30 |
4.65 |
| 2023-09-30 |
45.99 |
$12.43 |
3.70 |
| 2023-06-30 |
57.47 |
$12.07 |
4.76 |
| 2023-03-31 |
37.50 |
$11.39 |
3.29 |
| 2022-12-31 |
28.02 |
$10.99 |
2.55 |
| 2022-09-30 |
28.10 |
$10.39 |
2.70 |
| 2022-06-30 |
34.79 |
$10.19 |
3.41 |
| 2022-03-31 |
35.90 |
$9.84 |
3.65 |
| 2021-12-31 |
23.29 |
$9.34 |
2.49 |
| 2021-09-30 |
19.01 |
$8.97 |
2.12 |
| 2021-06-30 |
20.16 |
$9.74 |
2.07 |
| 2021-03-31 |
18.32 |
$9.45 |
1.94 |
| 2020-12-31 |
20.11 |
$9.45 |
2.13 |
| 2020-09-30 |
18.75 |
$9.49 |
1.98 |
| 2020-06-30 |
22.46 |
$9.32 |
2.41 |
| 2020-03-31 |
14.84 |
$9.14 |
1.62 |
| 2019-12-31 |
19.29 |
$9.18 |
2.10 |
| 2019-09-30 |
19.83 |
$9.19 |
2.16 |
| 2019-06-30 |
21.11 |
$9.16 |
2.31 |
| 2019-03-31 |
20.43 |
$8.07 |
2.53 |
| 2018-12-31 |
19.90 |
$7.81 |
2.55 |
| 2018-09-30 |
19.24 |
$7.39 |
2.60 |
| 2018-06-30 |
15.26 |
$6.91 |
2.21 |
| 2018-03-31 |
18.75 |
$7.01 |
2.67 |
| 2017-12-31 |
19.24 |
$7.16 |
2.69 |
| 2017-09-30 |
17.87 |
$7.20 |
2.48 |
| 2017-06-30 |
17.86 |
$7.21 |
2.48 |
| 2017-03-31 |
14.50 |
$7.08 |
2.05 |
| 2016-12-31 |
18.42 |
$7.12 |
2.59 |
| 2016-09-30 |
18.97 |
$7.13 |
2.66 |
| 2016-06-30 |
16.12 |
$6.82 |
2.36 |
| 2016-03-31 |
12.00 |
$6.60 |
1.82 |
| 2015-12-31 |
14.23 |
$6.54 |
2.18 |
| 2015-09-30 |
11.69 |
$6.28 |
1.86 |
| 2015-06-30 |
17.58 |
$6.29 |
2.79 |
| 2015-03-31 |
14.96 |
$6.25 |
2.39 |
| 2014-12-31 |
11.61 |
$6.31 |
1.84 |
| 2014-09-30 |
11.65 |
$6.34 |
1.84 |
| 2014-06-30 |
10.01 |
$6.45 |
1.55 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.009B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
